A Novel Diagnostic Nomogram for Noninvasive Evaluating Liver Fibrosis in Patients with Chronic Hepatitis B Virus Infection

Table 1

Comparing patients’ baseline demographic characteristics and clinical and pathological data between training dataset and validation dataset.

Characteristics	Training dataset	Validation dataset
	(%)	(%)
Gender
Male	237 (66.76)	97 (63.40)	0.464
Female	118 (33.24)	56 (36.60)
Age (yrs)			0.828
Significant fibrosis
No	209 (58.87)	92 (60.13)	0.791
Yes	146 (41.13)	61 (39.87)
LSM (kPa)			0.293
Laboratory data
ALT (IU/L)			0.730
AST (IU/L)			0.549
TBIL (μmol/L)			0.541
DBIL (μmol/L)			0.520
ALP (IU/L)			0.773
GGT (IU/L)			0.793
CHE (IU/L)			0.540
TP (g/L)			0.951
ALB (g/L)			0.277
GLO (g/L)			0.721
WBC (×10^9/L)			0.541
RBC (×10^12/L)			0.067
HGB (g/L)			0.224
PLT (×10^9/L)			0.055
PT (S)			0.892

Data were presented as (%), , or median (interquartile range). LSM: liver stiffness measurement; ALT: alanine aminotransferase; AST: aspartate aminotransferase; TBIL: total bilirubin; DBIL: directed bilirubin; ALP: alkaline phosphatase; GGT: γ-glutamyl transferase; CHE: cholinesterase; TP: total protein; ALB: albumin; GLO: globulin; WBC: white blood cell; RBC: red blood cell; HGB: hemoglobin; PLT: platelet count; PT: prothrombin time.